Isatin hybrids and their anti-tuberculosis activity

被引：237
作者：
Xu, Zhi [1 ]
Zhang, Shu [2 ]
Gao, Chuan [3 ]
Fan, Jing [4 ]
Zhao, Feng [3 ]
Lv, Zao-Sheng [1 ]
Feng, Lian-Shun [1 ,3 ,5 ]
机构：
[1] Wuhan Univ Sci & Technol, Wuhan 430081, Peoples R China
[2] Pony Testing Int Grp, Wuhan 430034, Peoples R China
[3] WuXi AppTec, Wuhan 430075, Peoples R China
[4] Hengshui Univ, Hengshui 053000, Peoples R China
[5] Peking Univ, Synthet & Funct Biomol Ctr, Beijing 100871, Peoples R China
来源：
CHINESE CHEMICAL LETTERS | 2017年 / 28卷 / 02期
关键词：
Isatin hybrids; Mycobacterium tuberculosis; Quinolone; Structure-activity relationship; Review; VITRO ANTIMYCOBACTERIAL ACTIVITY; MYCOBACTERIUM-TUBERCULOSIS; MOLECULAR HYBRIDIZATION; MANNICH-BASES; ANTI-HIV; DERIVATIVES; DESIGN; ANALOGS; ANTIBACTERIAL; ANTIMALARIAL;
D O I：
10.1016/j.cclet.2016.07.032
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
Tuberculosis (TB) is one of the most common and even fatal infectious diseases known to mankind. Millions of new cases are reported every year over the world, and one-third of the world's population is potentially infected with mycobacteria tuberculosis (MTB). Research to develop novel anti-TB drugs led to the identification of several isatin-based antimycobacterial agents, among which a number of potential candidates displayed excellent antimycobacterial activity and were found to be free of cytotoxicity. This review outlines the advances in the application of isatin hybrids as antimycobacterial agents and the critical aspects of design and structure-activity relationship of these derivatives. (C) 2016 Chinese Chemical Society and Institute of Materia Medica, Chinese Academy of Medical Sciences.
引用
收藏
页码：159 / 167
页数：9
相关论文
共 44 条
[11]  
Crofton J., 1997, GUIDELINES MANAGEMEN
[12]   In vitro antimycobacterial activity of newly synthesised S-alkylisothiosemicarbazone derivatives and synergistic interactions in combination with rifamycins against Mycobacterium avium [J].
De Logu, A ;
Saddi, M ;
Onnis, V ;
Sanna, C ;
Congiu, C ;
Borgna, R ;
Cocco, MT .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2005, 26 (01) :28-32
[13]   The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis [J].
Diacon, Andreas H. ;
Pym, Alexander ;
Grobusch, Martin ;
Patientia, Ramonde ;
Rustomjee, Roxana ;
Page-Shipp, Liesl ;
Pistorius, Christoffel ;
Krause, Rene ;
Bogoshi, Mampedi ;
Churchyard, Gavin ;
Venter, Amour ;
Allen, Jenny ;
Palomino, Juan Carlos ;
De Marez, Tine ;
van Heeswijk, Rolf P. G. ;
Lounis, Nacer ;
Meyvisch, Paul ;
Verbeeck, Johan ;
Parys, Wim ;
de Beule, Karel ;
Andries, Koen ;
Mc Neeley, David F. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (23) :2397-2405
[14]  
Dighe R., 2011, DER PHARM CHEM, V3, P418, DOI DOI 10.1016/J.EJMECH.2007.09.025
[15]   Design, Synthesis and Antitubercular Activity of Certain Nicotinic Acid Hydrazides [J].
Eldehna, Wagdy M. ;
Fares, Mohamed ;
Abdel-Aziz, Marwa M. ;
Abdel-Aziz, Hatem A. .
MOLECULES, 2015, 20 (05) :8800-8815
[16]  
Feng LS, 2012, CHEM RES CHINESE U, V28, P61
[17]   Synthesis and in vitro antimycobacterial activity of 8-OCH3 ciprofloxacin methylene and ethylene isatin derivatives [J].
Feng, Lian-Shun ;
Liu, Ming-Liang ;
Zhang, Shu ;
Chai, Yun ;
Wang, Bo ;
Zhang, Yi-Bin ;
Lv, Kai ;
Guan, Yan ;
Guo, Hui-Yuan ;
Xiao, Chun-Ling .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2011, 46 (01) :341-348
[18]   Synthesis and in vitro antimycobacterial activity of balofloxacin ethylene isatin derivatives [J].
Feng, Lian-Shun ;
Liu, Ming-Liang ;
Wang, Bo ;
Chai, Yun ;
Hao, Xue-Qin ;
Meng, Shuai ;
Guo, Hui-Yuan .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (08) :3407-3412
[19]   Isatin derivatives, a novel class of transthyretin fibrillogenesis inhibitors [J].
Gonzalez, Asensio ;
Quirante, Josefina ;
Nieto, Joan ;
Almeida, Maria Rosario ;
Saraiva, Maria Joao ;
Planas, Antoni ;
Arsequell, Gemma ;
Valencia, Gregorio .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (17) :5270-5273
[20]  
Gupta S., 2011, Der Pharma Chemica, V3, P274
12345